Send us a text

 Summary:  The drug ads float images of happy people across the room, with a voiceover discussing the mechanism of actions of the drug (JAK inhibitor) along with an undercurrent of warnings and side effects of the drug.  One of the newer drug groups are these JAK inhibitors, an oral form of targeted immunotherapy.  This episode attempts to explain this drug group, and also discusses to whom exactly the drug companies are directing their ads.

 Topics:

·       Drug Ads 01:20

·       Opzelura 02:00

·       Targeted Immunotherapy 02:45

·       Monoclonal Antibodies (MABs) 03:15

·       JAK Inhibitors – small molecules 03:45

·       Risk-Benefit Discussion 14:30

·       Black Box Warnings 15:30

·       Monitor and Journal 19:00

·       Participate!

Questions and comments to [email protected]